COVID-19’s impact on logistics creating ripple effects in other industries

    Samantha Naidoo The impact of the COVID-19 pandemic on the global logistics industry is creating ripple effects that can be felt across every other industry. Supply chains are under increasing pressure as the free movement of goods become more restricted due to lockdown measures implemented by governments around the world. The logistics industry’s response to the pandemic will greatly influence how well other sectors of the economy are able to adapt to our new reality. The sector forms the backbone of global trade and is fundamental to the…

Read More

Consol Glass cancels R1.5-b manufacturing plant due to impact of Covid-19

  Consol Glass has indefinitely suspended construction of a new R1.5-billion glass manufacturing plant in Ekurhuleni.  Photo by Sandra Grünewald on Unsplash Consol Glass has indefinitely suspended construction of a new R1.5-billion glass manufacturing plant in Ekurhuleni due to the reduction of the demand for glass products driven by the pandemic. The reduction in demand is coupled with government’s actions to slow the spread of the virus, including bans on the sale of alcohol and restrictions on all on-premise consumption in the restaurant and hospitality industry. “The legal alcoholic beverages…

Read More

How the Covid-19 crisis is different from other financial disasters

The Covid-19 crisis is different to some of the other economic crises we’ve experienced in living memory for three key reasons, particularly when compared to the global financial crisis (GFC). During the GFC, many developed economies, because of the financial services aspect of the crisis, were significantly affected. “This time around, with Covid-19, we’ve also seen emerging markets facing a lot of pain and, in some instances, emerging markets actually contracted by even more,” according to Sanisha Packirisamy, economist at Momentum Investments. Manufacturing sectors came under pressure during the GFC,…

Read More

Novavax begins mid-stage study of Covid-19 vaccine in South Africa

Aug 17 (Reuters) – U.S. drug developer Novavax Inc said on Monday that it is starting a mid-stage study of its experimental COVID-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases. The Phase 2b trial study of NVX-CoV2373 will be conducted on about 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240 medically stable, HIV-positive adults, the company said in a statement. “Because South Africa is experiencing a winter surge of COVID-19 disease, this important Phase 2b clinical trial has the…

Read More

Five Things We Value More Because of COVID-19

Five Things We Value More Because of COVID-19

Read More

How the Coronavirus Pandemic Has Disrupted the Global Mining Industry

Some have called the COVID-19 crisis a black swan event. It has had an extreme impact and the world was unprepared for what has transpired, even though, in hindsight, it was not unexpected. The mining industry has also been caught up in the turmoil. While previous global economic downturns hold clues as to what will happen next, there are several aspects to this crisis without similarities to the other economic collapses that have affected the mining industry. A mining downturn like no other Mining industry downturns are usually due to…

Read More